Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Margaglione, M.
space
  arrow  Di Minno, G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Increased Risk for Venous Thrombosis in Carriers of the Prothrombin G->A20210 Gene Variant

right arrow Maurizio Margaglione, MD; Vincenzo Brancaccio, MD; Nicola Giuliani, MD; Giovanna D'Andrea, BS; Giuseppe Cappucci, BS; Luigi Iannaccone, BS; Gennaro Vecchione, BS; Elvira Grandone, MD; and Giovanni Di Minno, MD

15 July 1998 | Volume 129 Issue 2 | Pages 89-93

Background: A mutation in the prothrombin gene (G->A20210) has been associated with higher plasma prothrombin levels and an increased tendency for venous thrombosis.

Objective: To determine whether the prothrombin A20210 allele is independently associated with the occurrence of venous thrombosis.

Design: Case-control study.

Setting: Two thrombosis centers in southern Italy.

Patients: 281 consecutive patients with venous thrombosis confirmed by objective tests and 850 controls.

Measurements: Medical history was collected on standardized questionnaires. The presence of prothrombin G->A20210 and factor V Leiden mutations was determined by polymerase chain reaction. The presence of anticoagulant factors and prothrombin activity was determined by tests of function.

Results: In 150 controls, increased prothrombin activity (P < 0.001) was associated with the prothrombin A20210 allele. This allele was more frequent in patients than in controls (8.01% compared with 2.29%; P < 0.001) and was associated with an increased risk for thrombosis (odds ratio, 3.88 [95% CI, 2.23 to 6.74]). The increased prevalence of this allele was independent of the presence of the factor V Leiden mutation. After adjustment for sex, age, arterial thrombosis, and factor V Leiden mutation, the risk was still significantly elevated (odds ratio, 3.13 [CI, 1.89 to 5.21]). Moreover, the overall prevalence of inherited coagulation abnormalities was significantly higher in patients with thrombosis of the lower extremities than in patients with thrombosis of the upper extremities (odds ratio, 3.77 [CI, 1.10 to 12.93]). Fourteen patients carried both the prothrombin G->A20210 and factor V Leiden mutations.

Conclusions: The prothrombin A20210 allele is independently associated with the occurrence of venous thrombosis, particularly in patients with a history of thrombosis of the lower extremities.

Author and Article Information
space

From IRCCS, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Ospedale A. Cardarelli, Napoli, Italy; and Universita di Palermo, Palermo, Italy.
Requests for Reprints: Maurizio Margaglione, MD, Unita di Aterosclerosi e Trombosi, IRCCS, Casa Sollievo della Sofferenza, viale Cappuccini, San Giovanni Rotondo (FG) 71013, Italy.
Current Author Addresses: Drs. Margaglione, Giuliani, and Grandone and Mrs. D'Andrea, Mr. Cappucci, and Mr. Vecchione: Unita di Aterosclerosi e Trombosi, IRCCS, Casa Sollievo della Sofferenza, viale Cappuccini, San Giovanni Rotondo (FG) 71013, Italy.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
D. Colaizzo, L. Amitrano, L. Iannaccone, P. Vergura, F. Cappucci, E. Grandone, M. A. Guardascione, and M. Margaglione
Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings
J. Med. Genet., June 1, 2007; 44(6): 412 - 416.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Coppens, M. H. van de Poel, I. Bank, K. Hamulyak, J. van der Meer, N. J. Veeger, M. H. Prins, H. R. Buller, and S. Middeldorp
A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation
Blood, October 15, 2006; 108(8): 2604 - 2607.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
D. Bosler, J. Mattson, and D. Crisan
Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype: A Paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology
J. Mol. Diagn., September 1, 2006; 8(4): 420 - 425.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Feinbloom and K. A. Bauer
Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2043 - 2053.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
K. Saxena, M. Ranalli, N. Khan, C. Blanchong, and S. B. Kahwash
Fatal Stroke in a Child with Severe Iron Deficiency Anemia and Multiple Hereditary Risk Factors for Thrombosis
Clinical Pediatrics, March 1, 2005; 44(2): 175 - 180.
[PDF]


Home page
Nucleic Acids ResHome page
M. Sachchithananthan, S. J. Stasinopoulos, J. Wilusz, and R. L. Medcalf
The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 3'-end formation
Nucleic Acids Res., February 17, 2005; 33(3): 1010 - 1020.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Kearon
Long-Term Management of Patients After Venous Thromboembolism
Circulation, August 31, 2004; 110(9_suppl_1): I-10 - I-18.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Grandone, D. Colaizzo, P. Vergura, F. Cappucci, G. Vecchione, A. Lo Bue, E. Cittadini, and M. Margaglione
Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation
Hum. Reprod., August 1, 2004; 19(8): 1796 - 1799.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. Juul, A. Tybjaerg-Hansen, P. Schnohr, and B. G. Nordestgaard
Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population
Ann Intern Med, March 2, 2004; 140(5): 330 - 337.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. von Ahsen and M. Oellerich
The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system
Blood, January 15, 2004; 103(2): 586 - 593.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
R. D. McBane II
Genetically Determined Procoagulant States and Heparin Use
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2003; 7(4): 427 - 442.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
M. H. Eckman, J. K. Erban, S. K. Singh, and G. S. Kao
Screening for the Risk for Bleeding or Thrombosis
Ann Intern Med, February 4, 2003; 138(3): W-15 - W-24.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
S. R Deitcher and M. P. Gomes
Hypercoagulable state testing and malignancy screening following venous thromboembolic events
Vascular Medicine, February 1, 2003; 8(1): 33 - 46.
[Abstract] [PDF]


Home page
StrokeHome page
H. Austin, M. I. Chimowitz, H. A. Hill, S. Chaturvedi, L. R. Wechsler, R. J. Wityk, E. Walz, J. L. Wilterdink, B. Coull, C. A. Sila, et al.
Cryptogenic Stroke in Relation to Genetic Variation in Clotting Factors and Other Genetic Polymorphisms Among Young Men and Women * Editorial Comment
Stroke, December 1, 2002; 33(12): 2762 - 2768.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. E. Dalen
Pulmonary Embolism: What Have We Learned Since Virchow?: Natural History, Pathophysiology, and Diagnosis
Chest, October 1, 2002; 122(4): 1440 - 1456.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C. Legnani, G. Palareti, G. Guazzaloca, B. Cosmi, B. Lunghi, F. Bernardi, and S. Coccheri
Venous thromboembolism in young women. Role of thrombophilic mutations and oral contraceptive use
Eur. Heart J., June 2, 2002; 23(12): 984 - 990.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
Y. Mira, J. Todoli, R. Alonso, M. L. Mico, A. Vaya, F. Ferrando, A. Estelles, P. Villa, and J. Aznar
Factor V Leiden and Prothrombin G20210A in Relation to Arterial and/or Vein Rethrombosis: Two Cases
Clinical and Applied Thrombosis/Hemostasis, July 1, 2001; 7(3): 234 - 237.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
D. G. Federman and R. S. Kirsner
An Update on Hypercoagulable Disorders
Arch Intern Med, April 23, 2001; 161(8): 1051 - 1056.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
U. Seligsohn and A. Lubetsky
Genetic Susceptibility to Venous Thrombosis
N. Engl. J. Med., April 19, 2001; 344(16): 1222 - 1231.
[Full Text] [PDF]


Home page
BloodHome page
P. Simioni, P. Prandoni, A. W. A. Lensing, D. Manfrin, D. Tormene, S. Gavasso, B. Girolami, C. Sardella, M. Prins, and A. Girolami
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis
Blood, November 15, 2000; 96(10): 3329 - 3333.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Margaglione, V. Brancaccio, D. De Lucia, I. Martinelli, A. Ciampa, E. Grandone, and G. Di Minno
Inherited Thrombophilic Risk Factors and Venous Thromboembolism : Distinct Role in Peripheral Deep Venous Thrombosis and Pulmonary Embolism
Chest, November 1, 2000; 118(5): 1405 - 1411.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. J. Gonzalez Ordonez, J. M. Fernandez Carreira, M. V. Alvarez, L. Martin Sanchez, J. M. Medina Rodriguez, and E. Coto Garcia
A High Factor II/Factor X Functional Ratio Is Not a Useful Predictor of the FII G20210A Gene Mutation in Thromboembolic Patients Undergoing Oral Anticoagulant Treatment
Clin. Chem., June 1, 2000; 46(6): 886 - 887.
[Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
A. Nguyen
State-of-the-Art Review : Review and Management of Patients With the Prothrombin G20210A Polymorphism
Clinical and Applied Thrombosis/Hemostasis, April 1, 2000; 6(2): 94 - 99.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Irish
Renal allograft thrombosis: can thrombophilia explain the inexplicable?
Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2297 - 2303.
[Full Text] [PDF]


Home page
NEJMHome page
V. De Stefano, I. Martinelli, P. M. Mannucci, K. Paciaroni, P. Chiusolo, I. Casorelli, E. Rossi, and G. Leone
The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation
N. Engl. J. Med., September 9, 1999; 341(11): 801 - 806.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. R. Meinardi, P. M. Pelsma, H. Koning, J. van der Meer, and K. Hamulyak
Double-Homozygosity for Factor V Leiden and the Prothrombin Gene G20210A Variant in a Young Patient With Idiopathic Venous Thrombosis
Blood, September 1, 1999; 94(5): 1828 - 1829.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Margaglione, G. D'Andrea, N. Giuliani, V. Brancaccio, D. De Lucia, E. Grandone, V. De Stefano, P. A. Tonali, and G. Di Minno
Inherited Prothrombotic Conditions and Premature Ischemic Stroke : Sex Difference in the Association With Factor V Leiden
Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1751 - 1756.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. D. Rosenberg and W. C. Aird
Vascular-Bed-Specific Hemostasis and Hypercoagulable States
N. Engl. J. Med., May 20, 1999; 340(20): 1555 - 1564.
[Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1998 by the American College of Physicians.